Dietary Calcium Intake Not Associated with Bone Loss

The current findings reinforce the growing understanding that increases in dietary calcium intake are unlikely to affect the prevalence of and morbidity from postmenopausal osteoporosis. Thus, the authors suggest the advice provided to the public with regard to calcium intake be revised to incorporate this new information.

Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

Reference

Bristow SM, Horne AM, Gamble GD, et al. Dietary calcium intake and bone loss over 6 years in osteopenic postmenopausal women. J Clin Endocrinol Metab. 2019 Mar 21. pii: jc.2019-00111. [Epub ahead of print]

Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.

Current management of osteoporosis

ACR CONVERGENCE 2020—Bisphosphonates are an important treatment for millions of older Americans with osteoporosis because the drugs inhibit osteoclastic bone resorption to reduce the risk of painful, debilitating fractures.1 More than 20 years ago, data emerged that bisphosphonates have a long terminal half-life.2 So after years of therapy, could some patients take a drug holiday?…

Handpicked Reviews of Contemporary Literature

Unexpected Benefits of Bisphosphonates after Hip Fracture

Build Up Bone

Osteoporosis Experts Discuss Bisphosphonate Holidays

Reading Rheum

Related Articles